News Medical on MSN13h
Anthraquinone compound Kanglexin investigated for treatment of atherosclerosis
Atherosclerosis, a disease characterized by the accumulation of lipids and inflammatory cells in the arterial wall, is a ...
Innovative molecular therapies target and disrupt uncontrollable growth of cancer cells
Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...
Armed robbery in Revesby16h
FDA OKs Pfizer's ADCETRIS Combo for Relapsed Lymphoma
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application ...
PipelineReview.com23h
U.S. FDA Approves Pfizer’s ADCETRIS® Combination Regimen for the treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
NEW YORK, NY, USA I 12, 2025 I Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental ...